BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35709879)

  • 1. Insulin-like growth factor in Parkinson's disease is related to nonmotor symptoms and the volume of specific brain areas.
    Shi X; Zheng J; Ma J; Wang Z; Sun W; Li M; Huang S; Hu S
    Neurosci Lett; 2022 Jul; 783():136735. PubMed ID: 35709879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson's disease.
    Shi X; Zheng J; Ma J; Wang Z; Sun W; Li M; Huang S; Hu S
    Neurol Sci; 2022 Mar; 43(3):1747-1754. PubMed ID: 34405296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between serum IGF-1 and EGF levels and neuropsychiatric and cognitive in Parkinson's disease patients.
    Shi X; Zheng J; Ma J; Li D; Gu Q; Chen S; Wang Z; Sun W; Li M
    Neurol Sci; 2023 Mar; 44(3):881-887. PubMed ID: 36383265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of plasma SIRT1 levels and whole-brain gray matter volume in Parkinson's disease patients with cognitive impairment.
    Li X; Yang D; Ma J; Wei W; Zheng J; Fan Y; Liang K; Shi X; Li D; She Z; Qi X; Chen S
    Neurol Sci; 2024 Jan; 45(1):47-54. PubMed ID: 37718350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma insulin-like growth factor 1 is associated with cognitive impairment in Parkinson's disease.
    Ma J; Jiang Q; Xu J; Sun Q; Qiao Y; Chen W; Wu Y; Wang Y; Xiao Q; Liu J; Tang H; Chen S
    Dement Geriatr Cogn Disord; 2015; 39(5-6):251-6. PubMed ID: 25661865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma lipocalin-2 levels are associated with nonmotor symptoms and neuroimaging features in patients with Parkinson's disease.
    Fan Y; Li X; Ma J; Yang D; Liang K; Shen Y; Wei W; Dong L; Liu C; She Z; Qi X; Shi X; Gu Q; Zheng J; Li D
    J Neurosci Res; 2024 Feb; 102(2):e25303. PubMed ID: 38361408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma orexin-A concentrations are associated with the non-motor symptoms in Parkinson's disease patients.
    Huang S; Zhao Z; Ma J; Hu S; Li L; Wang Z; Sun W; Shi X; Li M; Zheng J
    Neurosci Lett; 2021 Jan; 741():135480. PubMed ID: 33161104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma arylsulfatase A levels are associated with cognitive function in Parkinson's disease.
    Li M; Shi X; Ma J; Sun W; Wang Z; Li D; Zheng J; Zhao Z; Gu Q; Chen S
    Neurol Sci; 2022 Aug; 43(8):4753-4759. PubMed ID: 35486332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
    Bernhard FP; Heinzel S; Binder G; Weber K; Apel A; Roeben B; Deuschle C; Maechtel M; Heger T; Nussbaum S; Gasser T; Maetzler W; Berg D
    PLoS One; 2016; 11(3):e0150552. PubMed ID: 26967642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease.
    Godau J; Herfurth M; Kattner B; Gasser T; Berg D
    J Neurol Neurosurg Psychiatry; 2010 May; 81(5):536-8. PubMed ID: 20176597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.
    Huang C; Ravdin LD; Nirenberg MJ; Piboolnurak P; Severt L; Maniscalco JS; Solnes L; Dorfman BJ; Henchcliffe C
    Dement Geriatr Cogn Disord; 2013; 35(3-4):183-96. PubMed ID: 23445555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.
    Ghazi Sherbaf F; Mohajer B; Ashraf-Ganjouei A; Mojtahed Zadeh M; Javinani A; Sanjari Moghaddam H; Shirin Shandiz M; Aarabi MH
    Front Endocrinol (Lausanne); 2018; 9():608. PubMed ID: 30450079
    [No Abstract]   [Full Text] [Related]  

  • 13. Nonmotor symptoms in essential tremor: Comparison with Parkinson's disease and normal control.
    Lee SM; Kim M; Lee HM; Kwon KY; Koh SB
    J Neurol Sci; 2015 Feb; 349(1-2):168-73. PubMed ID: 25641389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
    Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.
    Lee HM; Lee SS; Kim M; Kang SH; Seo WK; Kim JH; Koh SB
    Arch Gerontol Geriatr; 2015; 61(3):517-22. PubMed ID: 26183203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
    Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease.
    Liu R; Umbach DM; Peddada SD; Xu Z; Tröster AI; Huang X; Chen H
    Neurology; 2015 May; 84(21):2107-15. PubMed ID: 25925983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild cognitive impairment in Parkinson's disease is associated with decreased P300 amplitude and reduced putamen volume.
    Hünerli D; Emek-Savaş DD; Çavuşoğlu B; Dönmez Çolakoğlu B; Ada E; Yener GG
    Clin Neurophysiol; 2019 Aug; 130(8):1208-1217. PubMed ID: 31163365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the Reserve Hypothesis in Parkinson's Disease: A Longitudinal Study.
    Lee PC; Artaud F; Cormier-Dequaire F; Rascol O; Durif F; Derkinderen P; Marques AR; Bourdain F; Brandel JP; Pico F; Lacomblez L; Bonnet C; Brefel-Courbon C; Ory-Magne F; Grabli D; Klebe S; Mangone G; You H; Mesnage V; Brice A; Vidailhet M; Corvol JC; Elbaz A;
    Mov Disord; 2019 Nov; 34(11):1663-1671. PubMed ID: 31518456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease.
    Picillo M; Erro R; Santangelo G; Pivonello R; Longo K; Pivonello C; Vitale C; Amboni M; Moccia M; Colao A; Barone P; Pellecchia MT
    J Neurol; 2013 Jul; 260(7):1724-30. PubMed ID: 23400497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.